Barbara M. Buttin

1.2k total citations
28 papers, 858 citations indexed

About

Barbara M. Buttin is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Barbara M. Buttin has authored 28 papers receiving a total of 858 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Obstetrics and Gynecology, 12 papers in Reproductive Medicine and 9 papers in Molecular Biology. Recurrent topics in Barbara M. Buttin's work include Ovarian cancer diagnosis and treatment (11 papers), Endometrial and Cervical Cancer Treatments (10 papers) and Intraperitoneal and Appendiceal Malignancies (5 papers). Barbara M. Buttin is often cited by papers focused on Ovarian cancer diagnosis and treatment (11 papers), Endometrial and Cervical Cancer Treatments (10 papers) and Intraperitoneal and Appendiceal Malignancies (5 papers). Barbara M. Buttin collaborates with scholars based in United States, Greece and United Kingdom. Barbara M. Buttin's co-authors include Janet S. Rader, Thomas J. Herzog, Randall K. Gibb, David G. Mutch, Anna V. Hoekstra, Julian C. Schink, Diljeet K. Singh, John R. Lurain, Paul J. Goodfellow and Elizabeth M. Swisher and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Clinical Cancer Research.

In The Last Decade

Barbara M. Buttin

28 papers receiving 836 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara M. Buttin United States 16 272 264 250 245 234 28 858
Kari L. Ring United States 20 406 1.5× 377 1.4× 467 1.9× 302 1.2× 500 2.1× 74 1.3k
R. Tucker Burks United States 6 348 1.3× 193 0.7× 412 1.6× 132 0.5× 144 0.6× 9 706
Mervi Aavikko Finland 15 501 1.8× 203 0.8× 585 2.3× 186 0.8× 230 1.0× 27 1.3k
M F Kohler United States 7 280 1.0× 133 0.5× 132 0.5× 168 0.7× 263 1.1× 9 622
Karin Shih United States 18 561 2.1× 107 0.4× 546 2.2× 182 0.7× 204 0.9× 30 1.0k
J.A. Pike Canada 8 607 2.2× 168 0.6× 783 3.1× 160 0.7× 306 1.3× 11 1.1k
Hyun S. Shvartsman United States 9 438 1.6× 81 0.3× 120 0.5× 86 0.4× 194 0.8× 10 785
Derek S. Chiu Canada 12 318 1.2× 92 0.3× 353 1.4× 127 0.5× 164 0.7× 22 707
Hiroaki Kase Japan 16 453 1.7× 81 0.3× 448 1.8× 105 0.4× 94 0.4× 35 834
Jim Biagi Canada 10 275 1.0× 106 0.4× 252 1.0× 65 0.3× 158 0.7× 17 648

Countries citing papers authored by Barbara M. Buttin

Since Specialization
Citations

This map shows the geographic impact of Barbara M. Buttin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara M. Buttin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara M. Buttin more than expected).

Fields of papers citing papers by Barbara M. Buttin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara M. Buttin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara M. Buttin. The network helps show where Barbara M. Buttin may publish in the future.

Co-authorship network of co-authors of Barbara M. Buttin

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara M. Buttin. A scholar is included among the top collaborators of Barbara M. Buttin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara M. Buttin. Barbara M. Buttin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Santin, Alessandro D., Virginia L. Filiaci, Stefania Bellone, et al.. (2020). Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008). Gynecologic Oncology Reports. 31. 100532–100532. 11 indexed citations
3.
Strohl, Anna E., Stacey N. Akers, Wiam Bshara, et al.. (2016). Synuclein-γ (SNCG) expression in ovarian cancer is associated with high-risk clinicopathologic disease. Journal of Ovarian Research. 9(1). 75–75. 14 indexed citations
4.
Mori, Kenichi, Stacey N. Akers, Wiam Bshara, et al.. (2013). Gamma synuclein expression in ovarian cancer. Gynecologic Oncology. 131(1). 272–272. 2 indexed citations
5.
Aponte, Margarita, Zhaojian Liu, Irene Helenowski, et al.. (2012). Expression analysis of MIR182 and its associated target genes in advanced ovarian carcinoma. Modern Pathology. 25(12). 1644–1653. 39 indexed citations
6.
Hoekstra, Anna V., Alfred Rademaker, Diljeet K. Singh, et al.. (2009). The impact of robotics on practice management of endometrial cancer: transitioning from traditional surgery. International Journal of Medical Robotics and Computer Assisted Surgery. 5(4). 392–397. 52 indexed citations
7.
Berry, Emily, Kellie S. Matthews, Diljeet K. Singh, et al.. (2009). An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer. Gynecologic Oncology. 113(1). 63–67. 16 indexed citations
8.
Hoekstra, Anna V., John R. Lurain, Barbara M. Buttin, et al.. (2009). Robotic surgery in gynecologic oncology: Impact on fellowship training. Gynecologic Oncology. 114(2). 168–172. 33 indexed citations
9.
Lowe, M. Patrick, Anna V. Hoekstra, Diljeet K. Singh, et al.. (2009). A comparison of robot-assisted and traditional radical hysterectomy for early-stage cervical cancer. Journal of Robotic Surgery. 3(1). 19–23. 18 indexed citations
10.
Viswanathan, Akila N., Barbara M. Buttin, & Anne Kennedy. (2008). Ovarian, Cervical, and Endometrial Cancer. Radiographics. 28(1). 289–307. 4 indexed citations
11.
Buttin, Barbara M. & Michael J. Moore. (2008). Thalidomide-induced reversible interstitial pneumonitis in a patient with recurrent ovarian cancer. Gynecologic Oncology. 111(3). 546–548. 6 indexed citations
12.
Hoekstra, Anna V., Jennifer Hardt, John R. Lurain, et al.. (2008). Chemosensitization of endometrial cancer cells through AKT inhibition involves FOXO1. Gynecologic Oncology. 108(3). 609–618. 31 indexed citations
13.
Gius, David, Eric Y. Chuang, Sheng Feng, et al.. (2007). Profiling Microdissected Epithelium and Stroma to Model Genomic Signatures for Cervical Carcinogenesis Accommodating for Covariates. Cancer Research. 67(15). 7113–7123. 76 indexed citations
14.
Buttin, Barbara M., Matthew A. Powell, Paul J. Goodfellow, et al.. (2006). Increased risk for abnormalities on perioperative colon screening in patients with microsatellite instability–positive endometrial carcinoma. International Journal of Gynecological Cancer. 16(6). 1980–1986. 2 indexed citations
15.
Im, Samuel S., Alan N. Gordon, Barbara M. Buttin, et al.. (2005). Validation of Referral Guidelines for Women With Pelvic Masses. Obstetrics and Gynecology. 105(1). 35–41. 61 indexed citations
16.
Lewin, Sharyn N., Barbara M. Buttin, Matthew A. Powell, et al.. (2005). Resource utilization for ovarian cancer patients at the end of life: How much is too much?. Gynecologic Oncology. 99(2). 261–266. 51 indexed citations
18.
Buttin, Barbara M., Matthew A. Powell, David G. Mutch, et al.. (2004). Penetrance and Expressivity of MSH6 Germline Mutations in Seven Kindreds Not Ascertained by Family History. The American Journal of Human Genetics. 74(6). 1262–1269. 52 indexed citations
19.
Buttin, Barbara M.. (2002). Epithelial ovarian tumors of low malignant potential: the role of microinvasion. Obstetrics and Gynecology. 99(1). 11–17. 50 indexed citations
20.
Buttin, Barbara M.. (2001). Meigs? syndrome with an elevated CA 125 from benign Brenner tumors. Obstetrics and Gynecology. 98(5). 980–982. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026